JESSICA VELIZ: Open Payments
NPI 1962040360 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,603 in 203 payments from 19 companies in 2025. Trend: 2023 $4,131 · 2024 $2,636 · 2025 $3,603
Food & beverage: $3,523Education: $80
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 52 | $964 |
| UCB, Inc. | 29 | $470 |
| Novartis Pharmaceuticals Corporation | 26 | $404 |
| Mallinckrodt Hospital Products Inc. | 24 | $347 |
| ABBVIE INC. | 13 | $258 |
| GENZYME CORPORATION | 5 | $218 |
| ANI Pharmaceuticals, Inc. | 13 | $209 |
| GlaxoSmithKline, LLC. | 18 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: Bimzelx, KRYSTEXXA, COSENTYX, ACTHAR, KEVZARA, TAVNEOS, RINVOQ, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
